In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

AbbVie’s ABBV stock has declined 8% in the past three months. A lot of this price decline is due to the poor performance of ...

The term therapeutic protein was first used to describe medicines that are genetically engineered versions of naturally occurring human proteins. Therapeutic proteins can be used to replace a protein ...

In the realm of healthcare innovation, therapeutic proteins emerge as catalysts for transformative advancements. According to the latest edition of the Global Therapeutic Protein ...

Editor’s Note: The Business Journal this week is honoring Gavin Herbert with our first ever Lifetime Achievement Recognition.

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

China is dealing with an outbreak of the human metapneumovirus (HMPV), five years after the Covid-19 pandemic ... for which there is no vaccine but whose symptoms resemble those of a cold.

Scientists and vaccine-makers broke speed records developing COVID-19 vaccines that have saved tens of millions of lives worldwide – and were the critical step to getting life back to normal.